| 000 | 01831 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515071200.0 | ||
| 264 | 0 | _c20071002 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a0934-0874 | ||
| 024 | 7 |
_a10.1111/j.1432-2277.2007.00502.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQian, Jiang-Ming | |
| 245 | 0 | 0 |
_aImprovement of recipient survival after small size graft liver transplantation in rats with preischemic manipulation or administering antisense against nuclear factor-kappaB. _h[electronic resource] |
| 260 |
_bTransplant international : official journal of the European Society for Organ Transplantation _cSep 2007 |
||
| 300 |
_a784-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlanine Transaminase _xblood |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aAspartate Aminotransferases _xblood |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 |
_aLiver _xpathology |
| 650 | 0 | 4 |
_aLiver Transplantation _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNF-kappa B _xgenetics |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xtherapeutic use |
| 650 | 0 | 4 | _aOrgan Size |
| 650 | 0 | 4 | _aPostoperative Period |
| 650 | 0 | 4 | _aPreoperative Care |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTransplants |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aZhang, Hao | |
| 700 | 1 | _aWu, Xiao-Feng | |
| 700 | 1 | _aLi, Guo-Qiang | |
| 700 | 1 | _aChen, Xiao-Ping | |
| 700 | 1 | _aWu, Jian | |
| 773 | 0 |
_tTransplant international : official journal of the European Society for Organ Transplantation _gvol. 20 _gno. 9 _gp. 784-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1432-2277.2007.00502.x _zAvailable from publisher's website |
| 999 |
_c17075411 _d17075411 |
||